Water-soluble associative amphoteric polymer as a rheology modifier for subterranean treatments
US-2024199939-A1 · Jun 20, 2024 · US
US10696801B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10696801-B2 |
| Application number | US-201615575704-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 27, 2016 |
| Priority date | May 27, 2015 |
| Publication date | Jun 30, 2020 |
| Grant date | Jun 30, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A gas hydrate hydrogel inhibitor comprising at least one polymer hydrogel particle having from 50 to 100% hydrogel content, the at least one polymer hydrogel particle including an inhibitor selected from the group consisting of: at least one thermodynamic hydrate inhibitor, at least one kinetic hydrate inhibitor, or a combination thereof.
Opening claim text (preview).
The invention claimed is: 1. A gas hydrate hydrogel inhibitor comprising at least one polymer hydrogel particle having from 50 to 100% hydrogel content, the at least one polymer hydrogel particle including an inhibitor comprising at least one thermodynamic hydrate inhibitor, at least one kinetic hydrate inhibitor, or a combination thereof. 2. The gas hydrate hydrogel inhibitor according to claim 1 , wherein each polymer hydrogel particle comprises from 70 to 100% hydrogel content. 3. The gas hydrate hydrogel inhibitor according to claim 1 , wherein the hydrogel particle can typically swell and retain from 50 wt % up to 99 wt % water within the structure of the hydrogel particle. 4. The gas hydrate hydrogel inhibitor according to claim 1 , wherein the polymer hydrogel particles contain between 5 and 50 wt % of the thermodynamic inhibitor. 5. The gas hydrate hydrogel inhibitor according to claim 1 , wherein the polymer hydrogel particles contain kinetic hydrate inhibitor in aqueous inhibitor solution is from 0.01 to 10 wt. 6. The gas hydrate hydrogel inhibitor according to claim 1 , wherein the inhibitor is at least one of: absorbed into or formed with the hydrogel particle. 7. The gas hydrate hydrogel inhibitor according to claim 6 , wherein the hydrogel comprises a cross-linked polymer where a polymer network is the inhibitor. 8. The gas hydrate hydrogel inhibitor according to claim 7 , wherein a cross-linked polymer structure of the hydrogel comprises between 0.01% and 50% cross-linker, with the remaining content comprising a KHI polymer hydrogel. 9. The gas hydrate hydrogel inhibitor according to claim 1 , wherein the thermodynamic hydrate inhibitor comprises methanol, mono-ethylene glycol (MEG), diethylene glycol (DEG) or a combination thereof. 10. The gas hydrate hydrogel inhibitor according to claim 1 , wherein the kinetic hydrate inhibitor comprises homo- and co-polymers of at least one of N-vinyl pyrrolidone, N-vinyl caprolactam, vinylcaprolactam, vinylpyrrolidone, vinylpiperidone acryloylpyrrolidine, acryloylmorpholine, aspartamide, Oligomeric amine oxide, N-methyl-N-vinyl acetamide, N-isopropylacrylamide, ethylacrylaminde, diethylacrylamide, isobutylacrylamide, isopropylmethacrylamide, butylacrylate or a combination thereof. 11. The gas hydrate hydrogel inhibitor according to claim 1 , wherein the kinetic hydrate inhibitor comprises poly(vinylpyrrolidone), polyvinylcaprolactam, polyethyloxazoline, poly-L-proline, polyacryloylpyrrolidine, polyethylmaleimide, ring-opened polyethyloxazoline, ring-closed polyethyloxazoline, polyetherdiamine, polyallyl isopentanamide, polypyrrolidinyl aspartate (polyAS), polyglyoxylpyrrolidine (polyGP), dodecyl-2-(2-caprolactamyl) ethanamide, modified AMPS polymers where R 1 is an alkyl tail of 1 to 6 carbon atoms and R 2 is H or Me, and wherein n is from 1 to 1000: Amidated maleic anhydride copolymers comprising: wherein M + is H + , a metal ion or a quarternary ammonium ion, and wherein n is from 1 to 1000, or a combination thereof. 12. The gas hydrate hydrogel inhibitor according to claim 1 , wherein the polymer hydrogel particles comprise aqueous content of between 70 and 99 wt %. 13. The gas hydrate hydrogel inhibitor according to claim 1 , wherein the polymer hydrogel particles comprise a polymer content of less than or equal to 15 wt %. 14. The gas hydrate hydrogel inhibitor according to claim 1 , wherein the polymer hydrogel particles comprise a cross-linked polymer used as hydrogel comprising a plurality of homogenous polymers comprising: polyacrylic acid, hydrolysed polyacrylamide or polyacrylamide-co-acrylic acid, polyacrylamide-co-acrylic acid partial sodium salt, poly(acrylic acid-co-maleic acid), poly(N-isopropylacrylamide), polyvinylcaprolactam, or polyvinyl N-vinyl caprolactam. 15. A method of forming a gas hydrate hydrogel inhibitor comprising: providing a plurality of hydrogel particles having from 50 to 100% hydrogel content; and swelling the hydrogel particles with an aqueous inhibitor solution including an inhibitor comprising: at least one thermodynamic hydrate inhibitor, at least one kinetic hydrate inhibitor or a combination thereof. 16. The method according to claim 15 , wherein the inhibitor comprises the at least one thermodynamic hydrate inhibitor and the concentration of the at least one thermodynamic inhibitor in an aqueous inhibitor solution is from 5 to 50 wt %. 17. A method of forming a gas hydrate inhibitor comprising at least one polymer hydrogel particle having from 50 to 100% hydrogel content, the method comprising: forming a hydrogel with, around, or with and around at least one inhibitor, wherein the inhibitor comprising: at least one thermodynamic hydrate inhibitor, at least one kinetic hydrate inhibitor or a combination thereof. 18. The method according to claim 17 , wherein the inhibitor comprises the at least one kinetic hydrate inhibitor and the concentration of the kinetic hydrate inhibitor is from 0.01 to 10 wt %. 19. The method according to claim 15 , wherein the hydrogel particles are formed by: (i) providing a first solution comprising: (a) a polymer having a repeating monomer unit comprising at least two different pendant functional groups, wherein at least one of the at least two pendant functional groups is a carboxyl or activated carboxylate group; and (b) a cross-linking agent having at least two pendant functional groups capable of forming a covalent bond with the carboxyl or activated carboxylate group; and (ii) reacting the cross-linking agent with the polymer so that a cross-linked polymer is formed, wherein a desired hydrogel particle size is formed by either: suspending the first solution within a second solution, wherein the first solution is immiscible with the second solution, then subsequently reacting the cross-linking agent with the polymer; or freeze drying the cross-linked polymer; and then comminuting the freeze dried cross-linked polymer to form dried hydrogel particles of a desired size. 20. The method according to claim 17 , wherein the hydrogel particles are formed by: (i) providing a first solution comprising: (a) a polymer having a repeating monomer unit comprising at least two different pendant functional groups, wherein at least one of the at least two pendant functional groups is a carboxyl or activated carboxylate group; and (b) a cross-linking agent having at least two pendant functional groups capable of forming a covalent bond with the carboxyl or activated carboxylate group; and (ii) reacting the cross-linking agent with the polymer so that a cross-linked polymer is formed, wherein a desired hydrogel particle size is formed by either: suspending the first solution within a second solution, wherein the first solution is immiscible with the second solution, then subsequently reacting the cross-linking agent with the polymer; or freeze drying the cross-linked polymer; and then comminuting the freeze dried cross-linked polymer to form dried hydrogel particles of a desired size.
Compositions for preventing, limiting or eliminating depositions, e.g. for cleaning · CPC title
Macromolecular gels · CPC title
by a heterocyclic ring containing nitrogen · CPC title
Particle, bubble or droplet size · CPC title
Limiting or prohibiting hydrate formation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.